Trials / Conditions / Stage III Thyroid Gland Papillary Carcinoma
Stage III Thyroid Gland Papillary Carcinoma
3 registered clinical trials studyying Stage III Thyroid Gland Papillary Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer NCT01811212 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radio NCT00729157 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine NCT00559949 | National Cancer Institute (NCI) | Phase 2 |